LSTA vs TSM
Lisata Therapeutics Inc. (LSTA) versus TSM (TSM) — a side-by-side from cached financials, not a winner call.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
TSM (TSM) common stock.
Latest reported LSTA revenue for 2026-06-30 was $0. Net income was -$7.4M. LSTA currently screens at market cap $31.7M.
TSM does not have a complete income-statement cache yet.
LSTA currently screens at market cap $31.7M. TSM currently screens at market cap $0.
Not investment advice. Open the LSTA and TSM stock pages for the full models.
Not investment advice.